欧美成人在线视频,中文字幕人妻精品一区,www.av在线,2019中文在线观看免费观看电视剧,精品人妻一区二区三区蜜桃

OctreotideAcetate Injection
【Drug name】

Generic name:OctreotideAcetate Injection

English name:OctreotideAcetate Injection

Pinyin:CusuanAoqutai Zhusheye

【Ingredients】

Main ingredients:The main ingredient of this product is octreotide acetate.

Chemical name:Octreotide acetate, d-phenylalanyl-l-cysteyl l-phenylalanyl-l-tryptophenyl l-lysyl-threonyl-n - [(1R

Molecular formula:C49H66N10O10S2.xC2H4O2

molecular weight:1019.26.×60.02

Accessories:Lactic acid, mannitol, sodium bicarbonate, water for injection.

【Character】

This product is a clear colorless liquid.

【Indication】 To control the symptoms of acromegaly patients who cannot be adequately controlled by surgical or radiotherapy and to reduce the plasma levels of growth hormone (GH) and insulin-like growth factor-1 (igf-1). Acromegaly patients who are unable or unwilling to undergo surgery may also be treated, or patients with intermittent acromegaly who have not yet been effectively treated with radiotherapy.
Related information


[usage and dosage]

acromegaly

Start subcutaneous injection every 8 hours or 12 hours, 0.05-0.1 mg each time, and then make corresponding adjustment according to circulating GH, igf-1 level, clinical reaction and tolerance every month (target: GH less than 2.5 ng/ml; IGF normal range). The optimal daily dose for most patients is 0.2 to 0.3 mg. GH concentrations were measured every 6 months in patients receiving the same dose for a long period of time.

The maximum daily dose shall not exceed 1.5 mg, and the plasma GH level can be reduced as appropriate after several months of treatment by monitoring.

If there is no decrease in GH level and no clinical reaction within 1 month after the treatment, discontinuation should be considered.

Gastrointestinal endocrine tumor

Initially, one or two subcutaneous injections of 0.05 mg/day were administered, gradually increasing to 0.1 ~ 0.2 mg/day three times, depending on the clinical response and the hormone concentration excreted by the tumor (in the case of carcinoid, depending on the excretion of 5-hydroxyindoleacetic acid in urine) and tolerance. Higher doses may be required in individual cases. Maintenance dose varies from individual to individual.

Discontinue medication if clinical symptoms and laboratory tests do not improve within 1 week of administration.

To prevent complications after pancreatic surgery

Subcutaneous injection three times a day, 0.1 mg each time, for 7 consecutive days, the first dose at least 1 hour before surgery.

Esophagogastric varicose bleeding

Continuous intravenous drip of 0.025 mg/h for up to 5 days. Octreotide can be diluted with saline.

In cirrhosis patients with esophagogastric varicose bleeding, octreotide can be given continuous intravenous drip for 5 days at 0.05 mg/h.

Dosage for special patients

Liver insufficiency

In patients with cirrhosis, the half-life of the drug is prolonged, so the maintenance dose needs to be changed.

Renal insufficiency

Renal dysfunction has no effect on total exposure (AUC) after subcutaneous administration, so the dosage of octreotide does not need to be adjusted.

[adverse reactions]

The most frequently reported adverse reactions during octreotide therapy included gastrointestinal, neurological, hepatobiliary, and metabolic and nutritional disorders.

The most common adverse reactions to octreotide in clinical trials were diarrhea, abdominal pain, nausea, flatulence, headache, cholelithiasis, hyperglycemia, and constipation. Other common adverse reactions are dizziness, local pain, biliary sludge formation, thyroid dysfunction (such as decreased thyrotropin [TSH], total T4, and free T4), loose stool, impaired glucose tolerance, vomiting, weakness, and hypoglycemia.

Gastrointestinal disease

In rare cases, gastrointestinal adverse reactions may resemble acute intestinal obstruction with progressive abdominal distension, severe epigastric pain, abdominal tenderness, and muscle tension.

The incidence of gastrointestinal adverse events is known to decrease with the duration of continued treatment.

The occurrence of gastrointestinal adverse reactions can be reduced by avoiding meals before and after administration of octreotide acetate subcutaneously, i.e. between meals or before sleeping.

Injection site reaction

Subcutaneous injection site pain, tingling or burning sensation, accompanied by redness and swelling, rarely lasting more than 15 minutes. Local discomfort can be alleviated by bringing the solution to room temperature before injection or by using a concentrated solution to reduce the injection volume.

Metabolic and nutritional diseases

Although increased fat excretion has been detected in the stool, there is no evidence that long-term use of octreotide causes malnutrition due to poor absorption.

The pancreas

In very rare cases, acute pancreatitis has been reported hours or days prior to subcutaneous treatment with octreotide acetate and recovery after discontinuation. In addition, patients who have been treated subcutaneously with octreotide acetate have reported pancreatitis due to cholelithiasis.

Heart disease.

In patients with acromegaly and carcinoid syndrome, ECG changes such as QT interval extension, electrical axis deviation, early repolarization, low voltage, R/S conversion, early increase of R wave and non-specific st-t wave changes were observed. The association between these events and octreotide acetate has not been established, as most of these patients have underlying heart disease (see [cautions]].

List of adverse reactions in clinical studies

Adverse reactions to octreotide in clinical studies are listed in table 1.

Adverse drug reactions were sorted by frequency using the following criteria: very common (1/10), common (1/100, <1/10), rare (1/1,000, <1/100), rare (1/10,000, <1/1,000), and very rare (<1/10,000), including individual reports. Adverse reactions were ranked in descending order of severity in each frequency group.




QQ1
QQ2
QQ3
黄色欧美精品免费 | 91麻豆精品久久久久蜜臀 | 免费黄色十八摸在线观看 | 美女黄视频免费网站 | 欧美特一级aaaaa | 免费在线观看WWW视频 | 台湾佬中文娱乐网22 | 香蕉97人妻免费碰碰碰 | 我看一级毛片一级强奸片一级强暴片毛片 | 久久澡狠l澡欧美老妇 | 精品人妻无码一级A片 | 久久久久久免费一级A片 | 中文字幕在线免费看 | 国产美女裸体无遮挡免费 | 美女草草视频高清在线播放 | 蜜桃视频污在线免费观看 | 中文人妻AV久久人妻18 | 永久免费无码AV网站在线观看 | 7777人妻精品无码视频 | 国产人成视频在线观看 | 日本久久久久一级毛片将欣 | 97人妻人人揉人人躁人人免费 | 30分钟免费婬片A片 黄色美女视频在线观看 | 潮喷无码视频在线观看 | 四川少妇XXXⅩ性XXX | 成年人免费观看a级毛片 | 欧一美一交一乱一交免费看 | 国产精品久久国产愉拍 | 国产91足控脚交在线观看 | 国产精品免费免费视频 | 国产人成视频在线观看 | 性爱一级毛片丰满少妇 | 中国少妇大非洲黑人大黑吊 | 一交一性一色一伦一区二 | 国产一区二区精品丝袜 | 免费无码婬片AAAA片软件下 | 波多野结衣无码潮喷 | 午夜无码在线观看 | 黑人糟蹋人妻HD中文字幕 | 无码人妻一区二区三区在线 | 免费在线观看黄片视频 |